Subscribe
shutterstock_607718810_vchal
vchal / Shutterstock.com
14 November 2019EuropeRory O'Neill

Merck and Evotec strike CRISPR licensing deal

Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.


Editor's picks

A step too far? Why Stewart’s approach is dividing opinion
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

Editor's picks

Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025

More on this story

Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

More on this story

Americas
USITC investigates grey market IVF products
14 April 2020   The US International Trade Commission is investigating ‘grey market’ in vitro fertilisation products intended for the Turkish market, following a trademark complaint from German pharmaceutical company Merck KGaA.
Big Pharma
EU General Court sides with Merck in TM opposition
21 November 2019   A German individual has lost an appeal before the tribunal of the EU General Court, after his trademark registration was opposed by Merck.
Americas
Sigma-Aldrich submits CRISPR petition at USPTO
23 July 2019   Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley.

More features

Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?
Broad Institute wins appeal to restore CRISPR patent in Europe
BMS faces fresh lawsuit over alleged cancer drug monopoly
WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations
Boies Schiller Flexner adds three-strong litigation team